Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sepsis
MedTech
Cytovale gains momentum with $100M for its sepsis screening test
The company’s nine-figure series D follows up on the $84 million financing round it collected less than one year ago.
Conor Hale
Oct 10, 2024 12:00pm
Inflammatix collects $57M as it awaits FDA review of sepsis test
Sep 12, 2024 11:30am
FDA places hold on Zentalis’ WEE1 drug after two sepsis deaths
Jun 18, 2024 8:21am
Roche picks up Prenosis' sepsis AI tool for distribution
Apr 12, 2024 2:55pm
Enlivex defends sepsis data that sank stock
Apr 12, 2024 9:30am
Prenosis nabs de novo nod for AI-powered sepsis risk tool
Apr 5, 2024 1:08pm
